One in three babies admitted to neonatal intensive care unit will fail their school readiness assessment at age five, with consequences lasting into adulthood. A new project aims to give them a helping hand to fulfil their potential.
Cambridge researchers have discovered that an existing therapy which boosts protective immune cells in people who recently had heart attacks reduces blood vessel inflammation and may reduce the likelihood of future heart attacks.
A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-oestrogen treatment for women with breast cancer, a new Cambridge-led trial has found.
The Vice-Chancellor of the University of Cambridge, Professor Deborah Prentice, has asked Roland Sinker CBE, CEO of Cambridge University Hospitals, to lead a review into the delivery of inclusive innovation and growth for the University.
A Cambridge patient has become the first person in Europe to receive cutting-edge histotripsy treatment outside of a clinical trial, after the technology was fast-tracked by the Government - marking a major milestone in NHS cancer care.
Mortality after emergency abdominal surgery is more than three times higher in the least developed countries compared to the most developed. Yet among those who undergo surgery, injuries tend to be less severe – raising concerns that those most critically injured are not even reaching the operating theatre.
A new total-body PET scanner to be hosted in Cambridge – one of only a handful in the country – will transform our ability to diagnose and treat a range of conditions in patients and to carry out cutting-edge research and drug development.
Thousands of women who undergo radiotherapy for low-risk breast cancer could be spared some of the side effects of treatment after a study confirmed that more targeted treatments are just as effective at controlling the disease in the long term.
A teenager who has lost family members including her mother because of a rare genetic hereditary illness has become the first patient in the UK and Europe to have a new treatment developed by Cambridge researchers and approved for use on the NHS.
Researchers in Cambridge are calling for additional scans to be added to breast screening for women with very dense breasts. This follows a large-scale trial, which shows that extra scans could treble cancer detection for these women, potentially saving up to 700 lives a year in the UK.
© 2026 University of Cambridge
